CATHETER PRECISION INC (VTAK)
AMEXHealth CareMedical - DevicesSnapshot 2026-09-04
$0.21+6.82%
Close 2026-09-04 · 1-day change
AMEXHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · VTAK
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||
| Revenues | 1.9 | 0.8 | 0.4 | 0.4 | 0.0 | 0.0 | 4.4 | 7.2 | 6.3 |
| Total Revenues | — | — | — | 0.4 | 0.0 | — | 4.4 | 7.2 | 6.3 |
| Cost of Revenues | 1.0 | 0.1 | 0.0 | 0.0 | 0.2 | 1.6 | 2.2 | 8.9 | 4.2 |
| Gross Profit | 0.9 | 0.8 | 0.4 | 0.4 | (0.1) | (1.5) | (1.9) | (1.7) | 2.1 |
| Operating Expenses & Income | |||||||||
| Selling, General & Admin | 12.2 | 12.1 | 11.3 | 17.1 | 16.3 | 15.5 | 24.5 | 51.5 | 30.4 |
| R&D Expenses | — | — | 0.3 | 0.5 | 6.4 | 12.3 | 9.0 | 4.5 | 2.8 |
| Operating Income | (19.2) | (21.1) | (11.2) | (78.1) | (27.0) | (29.3) | (35.4) | (57.7) | (31.2) |
| Earnings from Continuing Operations | |||||||||
| Interest Expense | — | — | — | — | — | — | 0.1 | 0.3 | 0.0 |
| Interest & Investment Income | 0.0 | 0.0 | 0.1 | 0.3 | — | — | 0.1 | 1.0 | 0.4 |
| Net Interest Expenses | — | — | — | — | — | — | (0.0) | (0.8) | (0.3) |
| Other Non-Operating Income / Expenses | 5.3 | 1.6 | (2.3) | 7.5 | 0.1 | 2.0 | 0.1 | 0.8 | 0.3 |
| Asset Writedown | — | — | — | 1.5 | 1.5 | — | — | — | — |
| EBT, Incl. Unusual Items | (13.8) | (19.5) | (13.5) | (70.6) | (26.9) | (27.3) | (35.3) | (56.9) | (30.8) |
| Income Tax Expense | (0.6) | (1.8) | 3.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Earnings from Continuing Operations | — | — | — | — | (26.9) | (27.3) | (35.3) | — | — |
| Net Income | |||||||||
| Minority Interest | (0.2) | (0.5) | — | — | — | — | — | — | — |
| Net Income | (13.0) | (17.2) | (16.6) | (70.6) | (26.9) | (25.1) | (36.0) | (57.0) | (30.8) |
| Per Share | |||||||||
| Basic EPS | (4.70) | (15.90) | (6.68) | (129.88) | (25.98) | (248.22) | — | — | — |
| Diluted EPS | — | — | — | — | (25.98) | (248.22) | — | — | — |
| Basic Weighted Avg Shares | 2.8 | 1.1 | 3.3 | 0.5 | 1.0 | 0.1 | — | — | — |
| Diluted Weighted Avg Shares | — | — | — | — | 1.0 | 0.1 | — | — | — |
| Supplemental | |||||||||
| EBITDA | — | (19.0) | (9.1) | (76.0) | (26.5) | (27.7) | (33.0) | — | — |
| EBIT | (19.2) | (21.1) | (11.2) | (78.1) | (27.0) | (29.3) | (35.4) | (57.7) | (31.2) |
| Effective Tax Rate | 4.5% | — | — | 0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.